SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 103 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,409,000 | +25.3% | 362,327 | +63.1% | 0.01% | +33.3% |
| Q4 2015 | $3,520,000 | -26.2% | 222,133 | -28.6% | 0.01% | -33.3% |
| Q3 2015 | $4,771,000 | -54.2% | 311,251 | -27.3% | 0.01% | -47.1% |
| Q2 2015 | $10,408,000 | +16.6% | 428,131 | +11.6% | 0.02% | +6.2% |
| Q1 2015 | $8,923,000 | +7.5% | 383,795 | +15.9% | 0.02% | +6.7% |
| Q4 2014 | $8,301,000 | +39.0% | 331,024 | +72.3% | 0.02% | +36.4% |
| Q3 2014 | $5,974,000 | +142.4% | 192,090 | +101.6% | 0.01% | +175.0% |
| Q2 2014 | $2,465,000 | +92.1% | 95,273 | +52.8% | 0.00% | +100.0% |
| Q1 2014 | $1,283,000 | +18.7% | 62,359 | +9.1% | 0.00% | 0.0% |
| Q4 2013 | $1,081,000 | +4.1% | 57,164 | +12.4% | 0.00% | 0.0% |
| Q3 2013 | $1,038,000 | +29.3% | 50,857 | +32.8% | 0.00% | +100.0% |
| Q2 2013 | $803,000 | – | 38,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |